This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| Health | 253 |
| United | 252 |
| States | 229 |
| • | 227 |
| S. | 195 |
| AR | 174 |
| AMR | 174 |
| UTI | 159 |
| amoxicillin | 127 |
| CAP | 127 |
| Staphylococcus | 122 |
| MRSA | 117 |
| PCR | 114 |
| HIV | 113 |
| NDM-1 | 102 |
| Antimicrobial | 98 |
| ICU | 92 |
| FDA | 89 |
| GP | 86 |
| A | 86 |
| C | 83 |
| mg | 82 |
| E. | 80 |
| Society | 79 |
| Escherichia | 76 |
| America | 74 |
| ABRS | 74 |
| National | 73 |
| China | 72 |
| US | 70 |
| World | 69 |
| Pseudomonas | 69 |
| Infectious | 68 |
| Table | 62 |
| flagellin | 61 |
| AECB | 61 |
| Helicobacter | 60 |
| UK | 59 |
| New | 59 |
| GABHS | 59 |
| Disease | 59 |
| M. | 58 |
| HWW | 56 |
| H. | 56 |
| Diseases | 56 |
| CDC | 56 |
| B | 56 |
| C. | 54 |
| Global | 54 |
| TB | 54 |
| ± | 54 |
| RNA | 53 |
| Resistance | 52 |
| England | 52 |
| AP | 51 |
| Care | 50 |
| CA | 50 |
| azithromycin | 49 |
| Group | 49 |
| Fig | 49 |
| Vietnam | 47 |
| Streptococcus | 46 |
| Antibiotic | 46 |
| American | 45 |
| Europe | 44 |
| URTI | 44 |
| Organization | 44 |
| Control | 43 |
| Chlamydia | 43 |
| Klebsiella | 43 |
| sha | 42 |
| Research | 42 |
| IV | 42 |
| Development | 42 |
| Bangladesh | 42 |
| meta | 41 |
| HCV | 41 |
| Asia | 41 |
| Africa | 41 |
| Legionella | 40 |
| Antibiotics | 40 |
| Institute | 40 |
| SOR | 40 |
| N | 40 |
| Medical | 39 |
| II | 39 |
| Enterobacteriaceae | 39 |
| Department | 39 |
| AMX | 39 |
| DOI | 38 |
| Drug | 38 |
| SARS | 37 |
| Pacific | 37 |
| F | 37 |
| Public | 36 |
| Prevention | 36 |
| Hospital | 36 |
| ED | 35 |
| D | 35 |
| Japan | 35 |
| India | 35 |
| RSV | 34 |
| IDSA | 34 |
| Human | 34 |
| Candida | 34 |
| USA | 34 |
| trimethoprim | 33 |
| Use | 33 |
| University | 33 |
| Microbiota | 33 |
| Management | 33 |
| DNA | 33 |
| CT | 33 |
| L | 32 |
| Food | 32 |
| HBV | 32 |
| Salmonella | 32 |
| PSI | 32 |
| URI | 32 |
| Study | 31 |
| Streptomyces | 31 |
| South | 31 |
| MP | 31 |
| Gram | 31 |
| Community | 31 |
| Medicine | 30 |
| European | 30 |
| Lyme | 30 |
| Mycoplasma | 30 |
| U.S. | 30 |
| Review | 30 |
| P. | 30 |
| May | 29 |
| International | 29 |
| France | 29 |
| COPD | 29 |
| CDI | 29 |
| Animal | 29 |
| SFTS | 28 |
| ID | 28 |
| AIDS | 28 |
| kg | 28 |
| lactam | 28 |
| sulfamethoxazole | 28 |
| ATS | 28 |
| West | 27 |
| Canada | 27 |
| colistin | 26 |
| clarithromycin | 26 |
| bla | 26 |
| Scheme | 26 |
| North | 26 |
| MRT | 26 |
| Korea | 26 |
| Committee | 26 |
| April | 26 |
| CRP | 25 |
| Centor | 25 |
| Acinetobacter | 25 |
| Figure | 25 |
| Gut | 25 |
| H5N1 | 25 |
| SMX | 25 |
| SSI | 25 |
| parainfluenza | 25 |
| aglycone | 24 |
| TMP | 24 |
| One | 24 |
| Hepatitis | 24 |
| Enterococcus | 24 |
| Centers | 24 |
| Efficacy | 23 |
| Clinical | 23 |
| Administration | 23 |
| HSV | 23 |
| Western | 23 |
| Matlab | 23 |
| meropenem | 22 |
| Ebola | 22 |
| Cochrane | 22 |
| Center | 22 |
| CI | 22 |
| I | 21 |
| Academy | 21 |
| Evaluation | 21 |
| Guidelines | 21 |
| Mycobacterium | 21 |
| IPC | 21 |
| LRTI | 21 |
| President | 21 |
| Azithromycin | 20 |
| Association | 20 |
| Pneumonia | 20 |
| AE | 20 |
| East | 20 |
| COVID-19 | 20 |
| tetracycline | 20 |
| G | 20 |
| HAV | 20 |
| MIC | 20 |
| catarrhalis | 20 |
| H | 20 |
| RT | 19 |
| City | 19 |
| General | 19 |
| KPC | 19 |
| PPD | 19 |
| MDR | 19 |
| Respiratory | 19 |
| Surveillance | 19 |
| VRE | 19 |
| multicentre | 19 |
| resistome | 19 |
| Infection | 18 |
| AS | 18 |
| Analysis | 18 |
| Australia | 18 |
| Cancer | 18 |
| Dr | 18 |
| Hib | 18 |
| Impact | 18 |
| Healthcare | 18 |
| Malaysia | 18 |
| ROS | 18 |
| Report | 18 |
| System | 18 |
| WWTP | 18 |
| carbapenem | 18 |
| clavulanate | 18 |
| PyBOP | 18 |
| Kingdom | 17 |
| NHS | 17 |
| L. | 17 |
| CRE | 17 |
| HPV | 17 |
| FUO | 17 |
| California | 17 |
| Region | 17 |
| Nile | 17 |
| T | 17 |
| SOS | 17 |
| Stewardship | 17 |
| Treatment | 17 |
| V | 17 |
| benzoxaborole | 17 |
| eremomycin | 17 |
| vancomycin | 17 |
| zanamivir | 17 |
| EMR | 16 |
| FilmArray | 16 |
| Epidemiology | 16 |
| Influenza | 16 |
| CFU | 16 |
| ABACUS | 16 |
| AAP | 16 |
| HH | 16 |
| Campylobacter | 16 |
| J | 16 |
| Moraxella | 16 |
| Primary | 16 |
| Program | 16 |
| oseltamivir | 16 |
| Survey | 16 |
| Trinidad | 16 |
| Zn | 16 |
| Microbiome | 16 |
| Plan | 15 |
| Box | 15 |
| College | 15 |
| Diagnosis | 15 |
| G. | 15 |
| June | 15 |
| Pakistan | 15 |
| SFTSV | 15 |
| Safety | 15 |
| Service | 15 |
| Thoracic | 15 |
| Union | 15 |
| nan | 15 |
| piperacillin | 15 |
| January | 14 |
| Brazil | 14 |
| Children | 14 |
| Framework | 14 |
| HGT | 14 |
| Haemophilus | 14 |
| Hong | 14 |
| ux | 14 |
| Penicillin | 14 |
| Precision | 14 |
| RADT | 14 |
| Services | 14 |
| WHO | 14 |
| linezolid | 14 |
| teicoplanin | 14 |
| OIE | 13 |
| Act | 13 |
| Amoxicillin | 13 |
| Dr. | 13 |
| GPs | 13 |
| HCAP | 13 |
| Latvia | 13 |
| M | 13 |
| Neisseria | 13 |
| ATCC | 13 |
| October | 13 |
| Physicians | 13 |
| Practice | 13 |
| September | 13 |
| Tyson | 13 |
| USDA | 13 |
| fl | 13 |
| mL | 13 |
| rhinosinusitis | 13 |
| β | 13 |
| Infections | 12 |
| Family | 12 |
| Detection | 12 |
| Delhi | 12 |
| Cryptococcus | 12 |
| Council | 12 |
| Anthropocene | 12 |
| Borrelia | 12 |
| Bank | 12 |
| Asthma | 12 |
| MRI | 12 |
| Action | 12 |
| A. | 12 |
| MDRO | 12 |
| Chlamydophila | 12 |
| Martinez | 12 |
| Zika | 12 |
| Multidrug | 12 |
| metronidazole | 12 |
| gonorrhoeae | 12 |
| glycopeptide | 12 |
| effl | 12 |
| acid | 12 |
| Ð | 12 |
| York | 12 |
| Nations | 12 |
| SBP | 12 |
| Prescribing | 12 |
| Netherlands | 12 |
| Science | 12 |
| GI | 11 |
| Guideline | 11 |
| III | 11 |
| INH | 11 |
| J. | 11 |
| LOS | 11 |
| K. | 11 |
| Kong | 11 |
| Mandell | 11 |
| Mechanisms | 11 |
| Medicare | 11 |
| FSIS | 11 |
| Fleming | 11 |
| BSG005 | 11 |
| FGD | 11 |
| Effect | 11 |
| ERS | 11 |
| Microbiology | 11 |
| C(7 | 11 |
| Bordetella | 11 |
| August | 11 |
| Aspergillus | 11 |
| Ala | 11 |
| Agriculture | 11 |
| ASP | 11 |
| AAFP | 11 |
| Microbial | 11 |
| CSF | 11 |
| Middle | 11 |
| Taiwan | 11 |
| NIV | 11 |
| tigecycline | 11 |
| quinolone | 11 |
| olivomycin | 11 |
| hepatitis | 11 |
| el | 11 |
| doc_id | 11 |
| alfa | 11 |
| WBC | 11 |
| VISA | 11 |
| UTIs | 11 |
| Therapy | 11 |
| polyene | 11 |
| TLR5 | 11 |
| POCT | 11 |
| Social | 11 |
| Network | 11 |
| November | 11 |
| Obama | 11 |
| PBS | 11 |
| OXA-48 | 11 |
| Patient | 11 |
| Practices | 11 |
| Quality | 11 |
| S | 11 |
| Singapore | 11 |
| Italy | 10 |
| Effectiveness | 10 |
| Improvement | 10 |
| HNS | 10 |
| HIV-1 | 10 |
| Gene | 10 |
| Fortané | 10 |
| Excellence | 10 |
| Epstein | 10 |
| Empiric | 10 |
| B. | 10 |
| ESBL | 10 |
| Database | 10 |
| DRSP | 10 |
| Centre | 10 |
| Barr | 10 |
| Baquero | 10 |
| Assessment | 10 |
| Advisory | 10 |
| AAO | 10 |
| MS | 10 |
| MERS | 10 |
| Molecular | 10 |
| baumannii | 10 |
| Spain | 10 |
| uenza | 10 |
| PCT | 10 |
| simplex | 10 |
| imipenem | 10 |
| cefaclor | 10 |
| Vancomycin | 10 |
| VIM-4 | 10 |
| Sweden | 10 |
| State | 10 |
| Strep | 10 |
| Sir | 10 |
| SXT | 10 |
| RMSF | 10 |
| R. | 10 |
| Proteus | 10 |
| Policy | 10 |
| Panel | 10 |
| PK | 10 |
| PD | 10 |
| Germany | 9 |
| Doxycycline | 9 |
| Enterobacter | 9 |
| Environment | 9 |
| FEZ-1 | 9 |
| Gause | 9 |
| M2 | 9 |
| H1N1 | 9 |
| H3N2 | 9 |
| Institutes | 9 |
| July | 9 |
| DMAE | 9 |
| Davies | 9 |
| 8) | 9 |
| Critical | 9 |
| Chronic | 9 |
| Central | 9 |
| CTX | 9 |
| CNS | 9 |
| CLSI | 9 |
| BV | 9 |
| Ambulatory | 9 |
| ARB | 9 |
| 63a | 9 |
| -male | 9 |
| K | 9 |
| clavulanic | 9 |
| Maastricht | 9 |
| Risk | 9 |
| Meta | 9 |
| viridans | 9 |
| glycopeptides | 9 |
| enterococci | 9 |
| drotrecogin | 9 |
| cefuroxime | 9 |
| aminoglycoside | 9 |
| Water | 9 |
| VIM-2 | 9 |
| Thailand | 9 |
| TLR | 9 |
| aspergillosis | 9 |
| Pneumocystis | 9 |
| NPs | 9 |
| PFOR | 9 |
| N. | 9 |
| NABX | 9 |
| NP | 9 |
| Ministry | 9 |
| Nature | 9 |
| Nipah | 9 |
| Norway | 9 |
| Novel | 9 |
| Government | 8 |
| Economic | 8 |
| Emergence | 8 |
| English | 8 |
| F. | 8 |
| Foundation | 8 |
| John | 8 |
| High | 8 |
| Congress | 8 |
| Laboratory | 8 |
| Legionnaires | 8 |
| MRMP | 8 |
| EU | 8 |
| 16S | 8 |
| CoV | 8 |
| C(2 | 8 |
| Binax | 8 |
| Bacteroides | 8 |
| BCG | 8 |
| Alexander | 8 |
| Agency | 8 |
| Adults | 8 |
| Access | 8 |
| AVRS | 8 |
| ARDS | 8 |
| ACP | 8 |
| Microbiol | 8 |
| March | 8 |
| Enterobacterales | 8 |
| NAHMS | 8 |
| Sciences | 8 |
| Neuraminidase | 8 |
| redosing | 8 |
| rRNA | 8 |
| pharyngotonsillitis | 8 |
| pH | 8 |
| ertapenem | 8 |
| cefazolin | 8 |
| Wolbachia | 8 |
| WNV | 8 |
| Trimethoprim | 8 |
| Trial | 8 |
| TDF | 8 |
| metapneumovirus | 8 |
| School | 8 |
| Penicillium | 8 |
| Rhinovirus | 8 |
| Origin | 8 |
| PHE | 8 |
| PPE | 8 |
| Pediatrics | 8 |
| PO | 8 |
| Perdue | 8 |
| specifi | 8 |
| Principles | 8 |
| QI | 8 |
| RABX | 8 |
| Fever | 7 |
| Herpes | 7 |
| Fmoc | 7 |
| Force | 7 |
| Fund | 7 |
| Genomics | 7 |
| Ghana | 7 |
| Greece | 7 |
| HDSS | 7 |
| Joint | 7 |
| Hygiene | 7 |
| I. | 7 |
| IC | 7 |
| ILI | 7 |
| IQR | 7 |
| LASSO | 7 |
| LPS | 7 |
| Earth | 7 |
| Fauci | 7 |
| Anthony | 7 |
| EUCAST | 7 |
| CCL20 | 7 |
| < | 7 |
| ARTI | 7 |
| Acquired | 7 |
| Agricultural | 7 |
| Lung | 7 |
| Assembly | 7 |
| BAL | 7 |
| CJD | 7 |
| EBV | 7 |
| CURB-65 | 7 |
| CXCL1 | 7 |
| Cape | 7 |
| D. | 7 |
| Data | 7 |
| Defense | 7 |
| Denmark | 7 |
| London | 7 |
| Gloucestershire | 7 |
| MGEs | 7 |
| favipiravir | 7 |
| Task | 7 |
| Technology | 7 |
| Virus | 7 |
| Working | 7 |
| Zealand | 7 |
| amantadine | 7 |
| amikacin | 7 |
| ceftazidime | 7 |
| kanamycin | 7 |
| Surgical | 7 |
| los | 7 |
| mcr | 7 |
| monensin | 7 |
| niger | 7 |
| para | 7 |
| tazobactam | 7 |
| vétérinaire | 7 |
| MMR | 7 |
| Systematic | 7 |
| lactamase | 7 |
| Studies | 7 |
| Pasteur | 7 |
| Med | 7 |
| Scientific | 7 |
| Mexico | 7 |
| Model | 7 |
| Monitoring | 7 |
| NEC | 7 |
| NIH | 7 |
| OSA | 7 |
| Montefiore | 7 |
| Project | 7 |
| Proteobacteria | 7 |
| SD | 7 |
| SDD | 7 |
| Philippines | 7 |
| San | 7 |
| STI | 7 |
| Front | 6 |
| IE | 6 |
| IgM | 6 |
| IM | 6 |
| IL-6 | 6 |
| GN | 6 |
| HCAI | 6 |
| Great | 6 |
| FtsH | 6 |
| Immunization | 6 |
| Factors | 6 |
| Immune | 6 |
| Major | 6 |
| Inc. | 6 |
| Initiative | 6 |
| Intensive | 6 |
| Links | 6 |
| MD | 6 |
| MSM | 6 |
| Macrolide | 6 |
| McIsaac | 6 |
| Metallo | 6 |
| Michigan | 6 |
| Ethics | 6 |
| NSQIP | 6 |
| FDI | 6 |
| BL | 6 |
| Essential | 6 |
| Cambodia | 6 |
| Nigeria | 6 |
| 139a | 6 |
| AECOPD | 6 |
| Acute | 6 |
| Aedes | 6 |
| Agents | 6 |
| Antibacterial | 6 |
| BVD | 6 |
| C(4 | 6 |
| C(9 | 6 |
| CJFH | 6 |
| CoV-2 | 6 |
| Erg | 6 |
| Consensus | 6 |
| Coral | 6 |
| County | 6 |
| Cpf1 | 6 |
| David | 6 |
| E | 6 |
| EDs | 6 |
| EIA | 6 |
| ELISA | 6 |
| Economy | 6 |
| Eremomycin | 6 |
| NaBH | 6 |
| Plant | 6 |
| O'Neill | 6 |
| Vibrio | 6 |
| Warren | 6 |
| acyclovir | 6 |
| and(or | 6 |
| aztreonam | 6 |
| bacteriuria | 6 |
| boulardii | 6 |
| carbamoyl | 6 |
| der | 6 |
| difficile | 6 |
| doxycycline | 6 |
| ethambutol | 6 |
| faecalis | 6 |
| galactomannan | 6 |
| granulocytopenia | 6 |
| heliomycin | 6 |
| i.v | 6 |
| mm | 6 |
| posaconazole | 6 |
| rimantadine | 6 |
| transthoracic | 6 |
| tratamiento | 6 |
| vanA | 6 |
| voriconazole | 6 |
| Origins | 6 |
| | | 6 |
| WGS | 6 |
| spinosyns | 6 |
| Veterinary | 6 |
| SPS | 6 |
| PCV13 | 6 |
| Van | 6 |
| PBP | 6 |
| PCV7 | 6 |
| Piperacillin | 6 |
| Programme | 6 |
| Pulmonary | 6 |
| RR | 6 |
| Randomized | 6 |
| Rapid | 6 |
| Resource | 6 |
| People | 6 |
| STIs | 6 |
| TNF | 6 |
| VAP | 6 |
| Turkey | 6 |
| Scott | 6 |
| Tennessee | 6 |
| Texas | 6 |
| Statistics | 6 |
| Southeast | 6 |
| Symbiosis | 6 |
| Summary | 6 |
| Fidaxomicin | 5 |
| Hernando | 5 |
| HOBt | 5 |
| HAdV | 5 |
| HA | 5 |
| H3 | 5 |
| Gramnegative | 5 |
| Genome | 5 |
| Geneva | 5 |
| GM | 5 |
| GTA | 5 |
| Federal | 5 |
| GINA | 5 |
| GII | 5 |
| Future | 5 |
| Forum | 5 |
| Flagellin | 5 |
| Firmicutes | 5 |
| Finland | 5 |
| ICUs | 5 |
| Host | 5 |
| Listeria | 5 |
| IL-1β | 5 |
| Marshall | 5 |
| Farm | 5 |
| Nasopharyngeal | 5 |
| NDM | 5 |
| Mycorrhizal | 5 |
| Mg | 5 |
| Membrane | 5 |
| Measles | 5 |
| MazF | 5 |
| Martin | 5 |
| ML | 5 |
| Index | 5 |
| M1 | 5 |
| Lille | 5 |
| Life | 5 |
| Laxminarayan | 5 |
| LTBI | 5 |
| K211A | 5 |
| Journal | 5 |
| Institut | 5 |
| Inspection | 5 |
| Fed | 5 |
| Britain | 5 |
| FTC | 5 |
| Anti | 5 |
| Brain | 5 |
| Bennett | 5 |
| Beijing | 5 |
| Basel | 5 |
| Bacterial | 5 |
| Bacteria | 5 |
| Bacillus | 5 |
| BD | 5 |
| BC | 5 |
| Andersson | 5 |
| C(10 | 5 |
| Amado | 5 |
| ARV | 5 |
| APACHE | 5 |
| AHI | 5 |
| AHA | 5 |
| AFB | 5 |
| AAD | 5 |
| 11,12-cyclic | 5 |
| Nitrofurantoin | 5 |
| Bronchitis | 5 |
| CMV | 5 |
| FMT | 5 |
| DCC | 5 |
| FAO | 5 |
| Environmental | 5 |
| Egypt | 5 |
| Douglas | 5 |
| Discovery | 5 |
| Dis | 5 |
| Design | 5 |
| Dental | 5 |
| December | 5 |
| DAVANAT | 5 |
| CN | 5 |
| Commons | 5 |
| Colorado | 5 |
| Clin | 5 |
| Climate | 5 |
| Childhood | 5 |
| Chen | 5 |
| Chemical | 5 |
| Chap | 5 |
| Carnevale | 5 |
| Ni | 5 |
| Standards | 5 |
| Norwegian | 5 |
| amphotericin | 5 |
| coryza | 5 |
| chlortetracycline | 5 |
| cefepime | 5 |
| bronchoalveolar | 5 |
| broadspectrum | 5 |
| bacteremias | 5 |
| azole | 5 |
| aureolic | 5 |
| antibiogram | 5 |
| aeruginosa | 5 |
| eBox | 5 |
| Whitney | 5 |
| War | 5 |
| Wang | 5 |
| Wales | 5 |
| WAK | 5 |
| Valentine | 5 |
| USPSTF | 5 |
| USA300 | 5 |
| Tunkel | 5 |
| desosamine | 5 |
| effi | 5 |
| Toll | 5 |
| psittacosis | 5 |
| OC43 | 5 |
| ‡ | 5 |
| μg | 5 |
| zoster | 5 |
| virus | 5 |
| triclosan | 5 |
| ticarcillin | 5 |
| teichoic | 5 |
| tacrolimus | 5 |
| penicillin | 5 |
| erythromycin | 5 |
| nitrofurantoin | 5 |
| moiety | 5 |
| mirabilis | 5 |
| macrolide | 5 |
| ivermectin | 5 |
| itraconazole | 5 |
| intranasal | 5 |
| group | 5 |
| fi | 5 |
| Trichomonas | 5 |
| nitazoxanide | 5 |
| Tetracycline | 5 |
| Patients | 5 |
| Professor | 5 |
| Production | 5 |
| Ploufragan | 5 |
| Planetary | 5 |
| Phase | 5 |
| Pharyngotonsillitis | 5 |
| Pharyngitis | 5 |
| Pharmaceutical | 5 |
| Performance | 5 |
| Pathogen | 5 |
| Protection | 5 |
| Panton | 5 |
| PVL | 5 |
| PID | 5 |
| Oseltamivir | 5 |
| Organisation | 5 |
| Oral | 5 |
| Olivomycin | 5 |
| Telithromycin | 5 |
| Office | 5 |
| Prophylaxis | 5 |
| PPV23 | 5 |
| Protein | 5 |
| Smith | 5 |
| TasP | 5 |
| Team | 5 |
| Quantitative | 5 |
| Tan | 5 |
| TWAR | 5 |
| Systems | 5 |
| Supplementary | 5 |
| Springer | 5 |
| Sneeringer | 5 |
| TTE | 5 |
| Shigella | 5 |
| Rev | 5 |
| Saint | 5 |
| Saharan | 5 |
| Regional | 5 |
| SDG | 5 |
| Richard | 5 |
| Self | 5 |
| Resources | 5 |
| Guidance | 4 |
| Guinea | 4 |
| H1 | 4 |
| H7N9 | 4 |
| HDV | 4 |
| HEV | 4 |
| Heart | 4 |
| HPAI | 4 |
| Healthy | 4 |
| Hg | 4 |
| Hologenome | 4 |
| Home | 4 |
| Goals | 4 |
| IA | 4 |
| IDI | 4 |
| Gonzales | 4 |
| Executive | 4 |
| Garcia | 4 |
| Everolimus | 4 |
| El | 4 |
| IMP | 4 |
| Endocarditis | 4 |
| Enzyme | 4 |
| Erythromycin | 4 |
| Ethiopia | 4 |
| Exacerbations | 4 |
| GNP | 4 |
| Farms | 4 |
| Federation | 4 |
| Feed | 4 |
| FliC | 4 |
| Florence | 4 |
| Flu | 4 |
| IFN | 4 |
| Laboratories | 4 |
| Imamovic | 4 |
| Ltd | 4 |
| La | 4 |
| Les | 4 |
| Levesque | 4 |
| Levy | 4 |
| Li | 4 |
| List | 4 |
| MBL | 4 |
| Individual | 4 |
| MEDLINE | 4 |
| MOA | 4 |
| MacIsaac | 4 |
| Madrid | 4 |
| Mann | 4 |
| ESCMID | 4 |
| LP | 4 |
| LM | 4 |
| LGV | 4 |
| Knowledge | 4 |
| King | 4 |
| Kaposi | 4 |
| K211E | 4 |
| Joseph | 4 |
| Jean | 4 |
| James | 4 |
| JK | 4 |
| Ixodes | 4 |
| Istanbul | 4 |
| Island | 4 |
| Iran | 4 |
| Intranasal | 4 |
| Internal | 4 |
| Eastern | 4 |
| Behavior | 4 |
| Domains | 4 |
| Beta | 4 |
| BSG022 | 4 |
| BU | 4 |
| Bacteroidetes | 4 |
| Barrier | 4 |
| Bartlett | 4 |
| Bent | 4 |
| Biological | 4 |
| BDG | 4 |
| Biosystems | 4 |
| Boeckel | 4 |
| Book | 4 |
| Braman | 4 |
| Bratton | 4 |
| British | 4 |
| BSG003 | 4 |
| Antonio | 4 |
| Director | 4 |
| ACIP | 4 |
| Medicaid | 4 |
| -female | 4 |
| A1 | 4 |
| ABPA | 4 |
| ABR | 4 |
| AC | 4 |
| AMPK | 4 |
| Americans | 4 |
| APPropriate | 4 |
| Abstract | 4 |
| Acyclovir | 4 |
| Adenovirus | 4 |
| Adult | 4 |
| Affairs | 4 |
| Brittany | 4 |
| Buruli | 4 |
| Bush | 4 |
| Creutzfeldt | 4 |
| Collaborative | 4 |
| Company | 4 |
| Comparative | 4 |
| Connecticut | 4 |
| Corey | 4 |
| Creative | 4 |
| D124A | 4 |
| C208A | 4 |
| DHPS | 4 |
| DOT | 4 |
| DPhPC | 4 |
| DTH | 4 |
| Dent | 4 |
| Developmental | 4 |
| Co. | 4 |
| ClinicalTrials.gov | 4 |
| Class | 4 |
| Clarithromycin | 4 |
| Citrobacter | 4 |
| Ciprofloxacin | 4 |
| Chol | 4 |
| Chinese | 4 |
| Chandler | 4 |
| Challenge | 4 |
| Centres | 4 |
| Case | 4 |
| Carbapenemase | 4 |
| Caenorhabditis | 4 |
| COVID | 4 |
| CCGs | 4 |
| CCG | 4 |
| Mayr | 4 |
| First | 4 |
| Medicines | 4 |
| cytomegalovirus | 4 |
| cefoxitin | 4 |
| cefpodoxime | 4 |
| cephalothin | 4 |
| cephapirin | 4 |
| chloramphenicol | 4 |
| coli | 4 |
| eTable | 4 |
| bp | 4 |
| ehrlichiosis | 4 |
| fosfomycin | 4 |
| gentamicin | 4 |
| herpes | 4 |
| hygroscopicus | 4 |
| i | 4 |
| cefotaxime | 4 |
| betalactam | 4 |
| jejuni | 4 |
| Y | 4 |
| Waksman | 4 |
| Walsh | 4 |
| Wellcome | 4 |
| Wilson | 4 |
| Woods | 4 |
| XO | 4 |
| Yang | 4 |
| aureus | 4 |
| Zhang | 4 |
| Zhu | 4 |
| actinomycetes | 4 |
| acyl | 4 |
| ampicillin | 4 |
| antibioticus | 4 |
| immunocompromise | 4 |
| keto | 4 |
| Veterans | 4 |
| typhlitis | 4 |
| serogroup | 4 |
| sp | 4 |
| st | 4 |
| streptogramin | 4 |
| sulbactam | 4 |
| teixobactin | 4 |
| vaborbactam | 4 |
| ridinilazole | 4 |
| van | 4 |
| vulnificus | 4 |
| za | 4 |
| zabofloxacin | 4 |
| zhi | 4 |
| Methicillin | 4 |
| rifampin | 4 |
| qid | 4 |
| lactams | 4 |
| mucositis | 4 |
| lasalocid | 4 |
| maltophilia | 4 |
| mcr-1 | 4 |
| meningitidis | 4 |
| metagenomes | 4 |
| monocytogenes | 4 |
| multocida | 4 |
| qd | 4 |
| myalgias | 4 |
| neomycin | 4 |
| novo | 4 |
| pneumococcus | 4 |
| porins | 4 |
| pyrene-2,6-dione | 4 |
| W. | 4 |
| sap | 4 |
| VZV | 4 |
| Povidone | 4 |
| Pap | 4 |
| Parkin | 4 |
| Parkinson | 4 |
| Pharmacy | 4 |
| Phlebovirus | 4 |
| Pneumococcal | 4 |
| Progress | 4 |
| PDCA | 4 |
| Province | 4 |
| QTF | 4 |
| Qualitative | 4 |
| RWA | 4 |
| Reef | 4 |
| Reporting | 4 |
| PV | 4 |
| PDB | 4 |
| Russia | 4 |
| Nobel | 4 |
| V. | 4 |
| Microbes | 4 |
| Mouse | 4 |
| NAATs | 4 |
| NCI | 4 |
| NL63 | 4 |
| Nottingham | 4 |
| PCAB | 4 |
| Open | 4 |
| Otitis | 4 |
| Outbreak | 4 |
| Outcomes | 4 |
| Outpatient | 4 |
| Oxford | 4 |
| Resistant | 4 |
| OXA | 4 |
| SAEs | 4 |
| Thomas | 4 |
| Syst | 4 |
| T. | 4 |
| TLRs | 4 |
| ≥50 | 4 |
| TTSH | 4 |
| Theoretical | 4 |
| Tobago | 4 |
| Sydney | 4 |
| Toronto | 4 |
| Trends | 4 |
| U | 4 |
| UT | 4 |
| SAFS | 4 |
| Usage | 4 |
| Syndrome | 4 |
| Tract | 4 |
| Streptococcal | 4 |
| Sociedad | 4 |
| Sen | 4 |
| ST22-MRSA | 4 |
| Sephadex | 4 |
| Serratia | 4 |
| Short | 4 |
| Serotype | 4 |
| Scientists | 4 |
| Spach | 4 |
| Spanish | 4 |
| Spectrum | 4 |
| Station | 4 |
| Soviet | 4 |
| Stenotrophomonas | 4 |
| Guangdong | 3 |
| HAP | 3 |
| H7 | 3 |
| H5 | 3 |
| H2 | 3 |
| Genetic | 3 |
| Gold | 3 |
| Gleckman | 3 |
| Gillings | 3 |
| HB | 3 |
| Giardia | 3 |
| GlaxoSmithKline | 3 |
| Hodgkin | 3 |
| HIV-2 | 3 |
| HSV-2 | 3 |
| HW | 3 |
| His | 3 |
| Infant | 3 |
| Holstein | 3 |
| House | 3 |
| ICMJE | 3 |
| Identification | 3 |
| IgG | 3 |
| Illness | 3 |
| GU | 3 |
| Immunology | 3 |
| Gates | 3 |
| Fernando | 3 |
| GFI | 3 |
| GES | 3 |
| Emergency | 3 |
| Influences | 3 |
| Enteric | 3 |
| Eric | 3 |
| Española | 3 |
| Et | 3 |
| Ethical | 3 |
| Evolution | 3 |
| Extended | 3 |
| Faecal | 3 |
| Favipiravir | 3 |
| February | 3 |
| Florida | 3 |
| Fluoroquinolone | 3 |
| Fluoroquinolones | 3 |
| Fondi | 3 |
| Foods | 3 |
| Foster | 3 |
| Freedom | 3 |
| Fusarium | 3 |
| G.R. | 3 |
| G1 | 3 |
| G20 | 3 |
| GC | 3 |
| GDP | 3 |
| Infective | 3 |
| Louis | 3 |
| Inhibitors | 3 |
| Levin | 3 |
| Lilly | 3 |
| Linezolid | 3 |
| Ling | 3 |
| LpxC | 3 |
| Lusk | 3 |
| LytA | 3 |
| MALDI | 3 |
| MC | 3 |
| MCF | 3 |
| MCR-1 | 3 |
| MRC | 3 |
| MRM | 3 |
| MSSA | 3 |
| Mainous | 3 |
| Malaria | 3 |
| Mass | 3 |
| Maternal | 3 |
| Meeting | 3 |
| Member | 3 |
| Merck | 3 |
| Metagenomic | 3 |
| Micafungin | 3 |
| Mitchell | 3 |
| Mortality | 3 |
| Einstein | 3 |
| LexA | 3 |
| Le | 3 |
| Inpatients | 3 |
| Law | 3 |
| Integrated | 3 |
| Integrons | 3 |
| Interactions | 3 |
| Interventions | 3 |
| Interview | 3 |
| Intestinal | 3 |
| Investigators | 3 |
| Iodine | 3 |
| Israel | 3 |
| JGW | 3 |
| Jakob | 3 |
| Janeiro | 3 |
| Joshua | 3 |
| KOH | 3 |
| Kenya | 3 |
| Kim | 3 |
| Kinetics | 3 |
| Kohanski | 3 |
| Kyoto | 3 |
| LAIV | 3 |
| LDMPGFGAVA | 3 |
| LH | 3 |
| LR | 3 |
| Lactamase | 3 |
| Lake | 3 |
| Eli | 3 |
| Ben | 3 |
| Ehrlichia | 3 |
| Anticancer | 3 |
| Applied | 3 |
| Arcanobacterium | 3 |
| Atlantic | 3 |
| Audit | 3 |
| Authority | 3 |
| B2017 | 3 |
| BMD-3691 | 3 |
| BRICS | 3 |
| BSI | 3 |
| BTS | 3 |
| Bacteremia | 3 |
| Barry | 3 |
| Bay | 3 |
| Bell | 3 |
| Mourad | 3 |
| BioFire | 3 |
| Bioengineering | 3 |
| Biosynthesis | 3 |
| Blokesch | 3 |
| Blue | 3 |
| Boc | 3 |
| Br | 3 |
| Broad | 3 |
| C(11 | 3 |
| C(13 | 3 |
| Appendix | 3 |
| Animals | 3 |
| C(7)7C(10 | 3 |
| Anderson | 3 |
| -3 | 3 |
| 137a | 3 |
| 23S | 3 |
| A2 | 3 |
| AAA | 3 |
| ACE | 3 |
| ACE2 | 3 |
| AM | 3 |
| AMB | 3 |
| AMS | 3 |
| APHIS | 3 |
| APUA | 3 |
| ARS | 3 |
| ASO | 3 |
| ATP | 3 |
| Adoc | 3 |
| Al | 3 |
| Alan | 3 |
| Albuterol | 3 |
| Aldrich | 3 |
| Allergy | 3 |
| Altman | 3 |
| Americas | 3 |
| AmpC | 3 |
| Anaplasma | 3 |
| C(16 | 3 |
| C(8 | 3 |
| Ehrlich | 3 |
| Curvularia | 3 |
| DENV | 3 |
| DHFR | 3 |
| DR1242 | 3 |
| Davis | 3 |
| De | 3 |
| Deborah | 3 |
| Decision | 3 |
| Demographic | 3 |
| Dengue | 3 |
| Dentistry | 3 |
| Depression | 3 |
| Diagnostic | 3 |
| Diarrhoeal | 3 |
| Diet | 3 |
| Directigen | 3 |
| Documento | 3 |
| Duke | 3 |
| E4-isobutyryl | 3 |
| ECBSI | 3 |
| EMB | 3 |
| EORTC | 3 |
| ESI | 3 |
| ESPAUR | 3 |
| EV | 3 |
| Edman | 3 |
| DBU | 3 |
| Crisis | 3 |
| CART | 3 |
| Covid-19 | 3 |
| CC | 3 |
| CD4 | 3 |
| CMI | 3 |
| CO | 3 |
| CPK | 3 |
| Candidate | 3 |
| Carbapenem | 3 |
| Ceftaroline | 3 |
| Cell | 3 |
| Cephalexin | 3 |
| Chin | 3 |
| Clinic | 3 |
| Clostridioides | 3 |
| Co | 3 |
| Cold | 3 |
| Colombia | 3 |
| Colonization | 3 |
| Commensal | 3 |
| Commission | 3 |
| Comparison | 3 |
| Compound | 3 |
| Concept | 3 |
| Conditions | 3 |
| Contribution | 3 |
| Cosgrove | 3 |
| Mountain | 3 |
| ALS-008176 | 3 |
| Mucorales | 3 |
| aglycones | 3 |
| airways | 3 |
| aminomethyl | 3 |
| amoxicillinclavulanate | 3 |
| antibióticos | 3 |
| antitumour | 3 |
| autolysin | 3 |
| avibactam | 3 |
| benzo[cd | 3 |
| biofi | 3 |
| bocavirus | 3 |
| bronchopulmonary | 3 |
| bronchoscopic | 3 |
| cephalexin | 3 |
| chemoprophylaxis | 3 |
| chlamydia | 3 |
| clavulinate | 3 |
| clindamycin | 3 |
| clinicaltrials.gov | 3 |
| compound | 3 |
| consenso | 3 |
| department | 3 |
| derivative | 3 |
| disease | 3 |
| ed | 3 |
| empyema | 3 |
| aguda | 3 |
| affi | 3 |
| enterotoxigenic | 3 |
| aerogenes | 3 |
| Trichoderma | 3 |
| Trust | 3 |
| Tuberculosis | 3 |
| Tunisia | 3 |
| UN | 3 |
| UR | 3 |
| URIs | 3 |
| Unit | 3 |
| Update | 3 |
| Upper | 3 |
| Urinary | 3 |
| Utilisation | 3 |
| V3 | 3 |
| VIM | 3 |
| Value | 3 |
| Vital | 3 |
| WASP | 3 |
| Wastewater | 3 |
| Wilcoxon | 3 |
| William | 3 |
| X | 3 |
| XDR | 3 |
| Y. | 3 |
| adenitis | 3 |
| administration | 3 |
| en | 3 |
| enteroviruses | 3 |
| Toxoplasma | 3 |
| pediátricos | 3 |
| q6h | 3 |
| q8h | 3 |
| quinolones | 3 |
| recA | 3 |
| sobre | 3 |
| spp | 3 |
| superoxides | 3 |
| synthase | 3 |
| tachypnea | 3 |
| taxol | 3 |
| telithromycin | 3 |
| tid | 3 |
| topoisomerase | 3 |
| tularensis | 3 |
| turkey | 3 |
| tylosin | 3 |
| una | 3 |
| valacyclovir | 3 |
| viroid | 3 |
| vivo | 3 |
| ward | 3 |
| www.nature.com/nrmicro | 3 |
| βlactamase | 3 |
|  | 3 |
| Mucosal | 3 |
| polymyxin | 3 |
| papilledema | 3 |
| erm(B | 3 |
| pacientes | 3 |
| general | 3 |
| gyrase | 3 |
| heterodimeric | 3 |
| highdose | 3 |
| infecciones | 3 |
| infl | 3 |
| jeroveci | 3 |
| ke | 3 |
| ketolide | 3 |
| key | 3 |
| lactamases | 3 |
| levofloxacin | 3 |
| mRNA | 3 |
| mecA | 3 |
| metagenomic | 3 |
| micafungin | 3 |
| mid | 3 |
| min | 3 |
| mithramycin | 3 |
| mobilome | 3 |
| motilin | 3 |
| ng | 3 |
| nonbronchoscopic | 3 |
| olivin | 3 |
| oxytetracycline | 3 |
| Trade | 3 |
| las | 3 |
| Tock | 3 |
| Pediatr | 3 |
| Personnel | 3 |
| Peter | 3 |
| Petersen | 3 |
| Pharmaceuticals | 3 |
| Phenotypic | 3 |
| Philadelphia | 3 |
| Plantationocene | 3 |
| Political | 3 |
| Population | 3 |
| Posaconazole | 3 |
| Postgenomic | 3 |
| Pract | 3 |
| Practitioners | 3 |
| Preparedness | 3 |
| Prevalence | 3 |
| Preventive | 3 |
| Problem | 3 |
| Pyuria | 3 |
| QMRA | 3 |
| Qual | 3 |
| RCGP | 3 |
| REDOR | 3 |
| RV | 3 |
| Randomised | 3 |
| Rapamycin | 3 |
| Pentostatin | 3 |
| Paul | 3 |
| Recommendations | 3 |
| Pathogens | 3 |
| Multicentre | 3 |
| Thursday | 3 |
| NASS | 3 |
| NH | 3 |
| NICE | 3 |
| Nebraska | 3 |
| Neck | 3 |
| Non | 3 |
| Nonresponse | 3 |
| Norte | 3 |
| O | 3 |
| OAP | 3 |
| OR | 3 |
| Oligomycin | 3 |
| Omaha | 3 |
| Order | 3 |
| Otolaryngology | 3 |
| P388 | 3 |
| PCV | 3 |
| PIIPPI | 3 |
| PIV | 3 |
| PVP | 3 |
| Paecilomyces | 3 |
| Pasteurella | 3 |
| Pathogenesis | 3 |
| RecA | 3 |
| Panera | 3 |
| Resistome | 3 |
| Streptococci | 3 |
| Shortall | 3 |
| Sigma | 3 |
| Software | 3 |
| Soil | 3 |
| Solutions | 3 |
| Sp3 | 3 |
| Spe | 3 |
| Sputum | 3 |
| Stanford | 3 |
| Staphylococci | 3 |
| Stephen | 3 |
| Strategy | 3 |
| Subcommittee | 3 |
| Serotonin | 3 |
| Surface | 3 |
| Sustainable | 3 |
| Swann | 3 |
| Swedish | 3 |
| TOF | 3 |
| Taxonomy | 3 |
| Testing | 3 |
| The | 3 |
| Therapeutic | 3 |
| Reviews | 3 |
| Therapies | 3 |
| Throat | 3 |
| Severe | 3 |
| Sub | 3 |
| Series | 3 |
| SOD | 3 |
| Robin | 3 |
| Sepsis | 3 |
| Roche | 3 |
| Rocky | 3 |
| Rotavirus | 3 |
| Rousseau | 3 |
| RpoS | 3 |
| Rule | 3 |
| Rumen | 3 |
| Rio | 3 |
| Ruppe | 3 |
| Route | 3 |
| SPSS | 3 |
| Schiff | 3 |
| Seng | 3 |
| SelectSurvey | 3 |
| Second | 3 |
| Sci | 3 |
| River | 3 |
| Saccharopolyspora | 3 |
| Sabra | 3 |
| STROBE | 3 |
| Salt | 3 |
| SSTI | 3 |
| Haraway | 2 |
| Helic | 2 |
| Harb | 2 |
| Harrison | 2 |
| Hawaii | 2 |
| Head | 2 |
| Heijden | 2 |
| Heise | 2 |
| Herbivory | 2 |
| Hendriksen | 2 |
| Histoplasma | 2 |
| Hospitalization | 2 |
| Horizontal | 2 |
| Hormesis | 2 |
| Hospitals | 2 |
| Hobbes | 2 |
| HBsAg | 2 |
| Hantavirus | 2 |
| Haloferax | 2 |
| Guri | 2 |
| Huashan | 2 |
| Gunnar | 2 |
| Guérin | 2 |
| Guía | 2 |
| HAI | 2 |
| HBIG | 2 |
| HCW | 2 |
| HIV/ | 2 |
| HKU1 | 2 |
| HMGB1 | 2 |
| HMR | 2 |
| HN001 | 2 |
| HOMO | 2 |
| HTS | 2 |
| Hotel | 2 |
| Induced | 2 |
| Hughes | 2 |
| Information | 2 |
| IncF | 2 |
| IncI2 | 2 |
| IncQ | 2 |
| Indiana | 2 |
| Indonesia | 2 |
| Induction | 2 |
| Inhibition | 2 |
| InGeMICS | 2 |
| Innovation | 2 |
| Inpatient | 2 |
| Instituto | 2 |
| Int | 2 |
| Guide | 2 |
| Interest | 2 |
| Inactivation | 2 |
| Immunostimulatory | 2 |
| Hui | 2 |
| IMI | 2 |
| Humber | 2 |
| Hunter | 2 |
| Hypocholesterolemic | 2 |
| IARC | 2 |
| IL-18 | 2 |
| ILS | 2 |
| IMR | 2 |
| Immunogenicity | 2 |
| IOM | 2 |
| IT | 2 |
| Iarc | 2 |
| Idaho | 2 |
| Illinois | 2 |
| Immunity | 2 |
| Guillain | 2 |
| FT | 2 |
| Groups | 2 |
| Francisco | 2 |
| Farrell | 2 |
| Fate | 2 |
| Fe | 2 |
| Fenton | 2 |
| Field | 2 |
| File | 2 |
| Filippov | 2 |
| Final | 2 |
| Fine | 2 |
| Finnish | 2 |
| Fisheries | 2 |
| Flora | 2 |
| Fluconazole | 2 |
| Flurbiprofen | 2 |
| Foodborne | 2 |
| Fam | 2 |
| Facial | 2 |
| FRI | 2 |
| Experimental | 2 |
| Investigator | 2 |
| Ertapenem | 2 |
| Escape | 2 |
| Euler | 2 |
| Evolutionary | 2 |
| Exchange | 2 |
| Expert | 2 |
| FK506 | 2 |
| F.B. | 2 |
| FCS | 2 |
| FEV | 2 |
| FFP3 | 2 |
| FIGURE | 2 |
| FK | 2 |
| Form | 2 |
| Francisella | 2 |
| Grant | 2 |
| French | 2 |
| Gandra | 2 |
| Gantz | 2 |
| Gastroenterology | 2 |
| Gastrointestinal | 2 |
| Gaygısız | 2 |
| Gemifloxacin | 2 |
| Gerba | 2 |
| Ghany | 2 |
| Ghose | 2 |
| Gibco | 2 |
| Glide | 2 |
| Glycopeptide | 2 |
| Gostin | 2 |
| Grady | 2 |
| Grampositive | 2 |
| Galactomannan | 2 |
| Gaia | 2 |
| GVHD | 2 |
| Fusobacterium | 2 |
| Frequency | 2 |
| Friendship | 2 |
| Fromm | 2 |
| Frost | 2 |
| Fukui | 2 |
| Function | 2 |
| G.S.S. | 2 |
| GLOBE | 2 |
| GCs | 2 |
| GG | 2 |
| GII.4 | 2 |
| GISTAR | 2 |
| GIV | 2 |
| GL | 2 |
| Investigation | 2 |
| Monoclonal | 2 |
| Iraq | 2 |
| Missouri | 2 |
| MeLeu | 2 |
| Mechanism | 2 |
| Mediterranean | 2 |
| Melinda | 2 |
| Memorial | 2 |
| Mendoza | 2 |
| Metal | 2 |
| Methods | 2 |
| Metronidazole | 2 |
| Mexef | 2 |
| Mice | 2 |
| Michael | 2 |
| Microbiomes | 2 |
| Minimum | 2 |
| Minitab | 2 |
| McNulty | 2 |
| McLendon | 2 |
| MazE | 2 |
| MSU | 2 |
| MBBS | 2 |
| MCF-7 | 2 |
| MMWR | 2 |
| MO | 2 |
| MPH | 2 |
| MSRA | 2 |
| MTD | 2 |
| Mayo | 2 |
| Maestro | 2 |
| Magnus | 2 |
| Maillard | 2 |
| Manaia | 2 |
| Manchester | 2 |
| Manoharan | 2 |
| Mississippi | 2 |
| Mithramycin | 2 |
| Ireland | 2 |
| Mitomycin | 2 |
| NKT | 2 |
| NS | 2 |
| NSAIDS | 2 |
| NY | 2 |
| Nathan | 2 |
| Natural | 2 |
| Nervous | 2 |
| Networks | 2 |
| Neutrophil | 2 |
| Newcastle | 2 |
| Newsletter | 2 |
| Newton | 2 |
| Nguyen | 2 |
| Niche | 2 |
| Nicolle | 2 |
| NK | 2 |
| NGU | 2 |
| NGS | 2 |
| Mozambique | 2 |
| Models | 2 |
| Eradi | 2 |
| Monotherapy | 2 |
| Morbidity | 2 |
| Morris | 2 |
| Moyer | 2 |
| MsbA | 2 |
| NDM-1/ | 2 |
| Multi | 2 |
| Murine | 2 |
| NARMS | 2 |
| NCCLS | 2 |
| NCSP | 2 |
| NCT03391076 | 2 |
| MAP | 2 |
| MAC | 2 |
| M.N.Preobrazhenskaya | 2 |
| M.D. | 2 |
| Justice | 2 |
| K-12 | 2 |
| Kainer | 2 |
| Kansas | 2 |
| Kant | 2 |
| Karkman | 2 |
| Kenyon | 2 |
| Kettering | 2 |
| Kirchhelle | 2 |
| Klain | 2 |
| Koch | 2 |
| Koop | 2 |
| Korean | 2 |
| Kotnik | 2 |
| Kumamoto | 2 |
| Jungner | 2 |
| José | 2 |
| Jose | 2 |
| JSW | 2 |
| Isavuconazole | 2 |
| Islam | 2 |
| Islands | 2 |
| JE | 2 |
| JJ | 2 |
| JNJ | 2 |
| JULY | 2 |
| Jordan | 2 |
| Jansen | 2 |
| Janthinobacterium | 2 |
| Jennifer | 2 |
| Jolla | 2 |
| Jonas | 2 |
| Jones | 2 |
| L- | 2 |
| LAMP | 2 |
| LB | 2 |
| Long | 2 |
| Lionel | 2 |
| Lipinski | 2 |
| Lipstatin | 2 |
| Liu | 2 |
| Livingstone | 2 |
| Loire | 2 |
| Los | 2 |
| Lim | 2 |
| Lowe | 2 |
| Ltd. | 2 |
| Lye | 2 |
| Lys | 2 |
| M-27 | 2 |
| M-55 | 2 |
| Lin | 2 |
| Levofloxacin | 2 |
| LC | 2 |
| Larry | 2 |
| LRT | 2 |
| Lactam | 2 |
| Lactams | 2 |
| Lactobacillus | 2 |
| Lancet | 2 |
| Lanza | 2 |
| Lars | 2 |
| Leukocytosis | 2 |
| Larsson | 2 |
| Lay | 2 |
| Lee | 2 |
| Leg | 2 |
| Lemierre | 2 |
| Lerner | 2 |
| Ernst | 2 |
| Cheng | 2 |
| Epothilones | 2 |
| Bill | 2 |
| Bacteriophage | 2 |
| Badau | 2 |
| Baltimore | 2 |
| Bangla | 2 |
| Barbosa | 2 |
| Barcelona | 2 |
| Basil | 2 |
| Bayer | 2 |
| Becton | 2 |
| Behaviour | 2 |
| Beltran | 2 |
| Berdah | 2 |
| Berendonk | 2 |
| Berg | 2 |
| Bergdorfer | 2 |
| Bacteriologic | 2 |
| Bacteremic | 2 |
| Baccharis | 2 |
| Axis | 2 |
| Aureomycin | 2 |
| Author | 2 |
| Autism | 2 |
| Availability | 2 |
| Avian | 2 |
| Awareness | 2 |
| BACKGROUND | 2 |
| BSG019 | 2 |
| BALB | 2 |
| BASHH | 2 |
| BL21(DE3 | 2 |
| BLASTP | 2 |
| BMC | 2 |
| BSG018 | 2 |
| Bifidobacteria | 2 |
| Bio | 2 |
| CD33 | 2 |
| Biodiversity | 2 |
| Bunge | 2 |
| Burden | 2 |
| Burkholderia | 2 |
| C(11)7OH | 2 |
| C(3 | 2 |
| C(3)]Ala | 2 |
| C(33 | 2 |
| C57BL/6 | 2 |
| C57BL/6J | 2 |
| C59 | 2 |
| CAL02 | 2 |
| CAUTI | 2 |
| CCL | 2 |
| CCR5 | 2 |
| CD11c | 2 |
| Brown | 2 |
| Bronx | 2 |
| Bristol | 2 |
| Block | 2 |
| Biofilms | 2 |
| Bioinformatics | 2 |
| Biotechnology | 2 |
| Biotest | 2 |
| Birmingham | 2 |
| Bismuth | 2 |
| Bloomfield | 2 |
| Breast | 2 |
| Board | 2 |
| Boccuzzi | 2 |
| Bodey | 2 |
| Bohai | 2 |
| Borer | 2 |
| Boston | 2 |
| Aung | 2 |
| Augmentin | 2 |
| Attribution | 2 |
| Atlas | 2 |
| ARMS | 2 |
| ASEAN | 2 |
| AST | 2 |
| AUC | 2 |
| AUGUST | 2 |
| Aarestrup | 2 |
| Abbo | 2 |
| Abbott | 2 |
| Acquisition | 2 |
| Actb | 2 |
| Actinobacteria | 2 |
| Actinomadura | 2 |
| Actinomyces | 2 |
| Activity | 2 |
| Acyl | 2 |
| ANSORP | 2 |
| AMX+flagellin | 2 |
| AML | 2 |
| 34a | 2 |
| Nodulisporium | 2 |
| -Repor | 2 |
| -substituted | 2 |
| 117a | 2 |
| 2WHG | 2 |
| 30S | 2 |
| A121F | 2 |
| ALI | 2 |
| A4 | 2 |
| AA3 | 2 |
| AA4 | 2 |
| ABHR | 2 |
| ACME | 2 |
| AEs | 2 |
| Address | 2 |
| Adjunctive | 2 |
| Aeromonas | 2 |
| Approach | 2 |
| Amábile | 2 |
| Angeles | 2 |
| Anthracyclines | 2 |
| Antibody | 2 |
| Antigen | 2 |
| Application | 2 |
| Arbuscular | 2 |
| Amphotericin | 2 |
| Areces | 2 |
| Argentina | 2 |
| Armbruster | 2 |
| Aspergillosis | 2 |
| Associated | 2 |
| Atlanta | 2 |
| Amsel | 2 |
| Aminoglycosides | 2 |
| Aetiological | 2 |
| Alice | 2 |
| Aetiology | 2 |
| Afghanistan | 2 |
| Agrobacterium | 2 |
| Airway | 2 |
| Albert | 2 |
| Ali | 2 |
| Aljaro | 2 |
| Ambroxol | 2 |
| Allen | 2 |
| Allison | 2 |
| Am | 2 |
| AmBiLoad | 2 |
| Amazon | 2 |
| Amber | 2 |
| CD26 | 2 |
| CD45 | 2 |
| Epirubicin | 2 |
| Dnmt3a | 2 |
| Dairy | 2 |
| Daptomycin | 2 |
| Day | 2 |
| Declaration | 2 |
| Definitions | 2 |
| Dendroctonus | 2 |
| Dickinson | 2 |
| Diego | 2 |
| Difficile | 2 |
| Digital | 2 |
| Directive | 2 |
| Disclosure | 2 |
| Discourse | 2 |
| Disinfection | 2 |
| Disorder | 2 |
| Daily | 2 |
| Da | 2 |
| DS | 2 |
| D3 | 2 |
| Cxcl1 | 2 |
| Cxcl2 | 2 |
| Cycling | 2 |
| Cyclosporin | 2 |
| Cérvico | 2 |
| D'Costa | 2 |
| DA | 2 |
| DRACO | 2 |
| DC | 2 |
| DDD | 2 |
| DEET | 2 |
| DFA | 2 |
| DMSO | 2 |
| DPPA | 2 |
| Dl | 2 |
| Dolin | 2 |
| CEPI | 2 |
| Donna | 2 |
| Eco | 2 |
| Ecological | 2 |
| Economics | 2 |
| Ecosystem | 2 |
| Edelman | 2 |
| Editorial | 2 |
| Education | 2 |
| Edward | 2 |
| Efflux | 2 |
| Elizabeth | 2 |
| Em | 2 |
| Emerging | 2 |
| Endoscopy | 2 |
| Enterococci | 2 |
| Enticott | 2 |
| Echinacea | 2 |
| ESR | 2 |
| ERDF | 2 |
| Dutch | 2 |
| Dosage | 2 |
| Doxorubicin | 2 |
| Drinking | 2 |
| Drotrecogin | 2 |
| Drs | 2 |
| Duration | 2 |
| Dysbiosis | 2 |
| EPs | 2 |
| E4 | 2 |
| E4-isobutyrylolivomycin | 2 |
| EGDT | 2 |
| EH | 2 |
| EIAs | 2 |
| EPRS | 2 |
| Cultural | 2 |
| Cuevas | 2 |
| Cuba | 2 |
| Crystal | 2 |
| Ccl20 | 2 |
| Cef-3 | 2 |
| Ceftazidime | 2 |
| Ceftriaxone | 2 |
| Census | 2 |
| Cethromycin | 2 |
| Chancroid | 2 |
| Changes | 2 |
| Chapman | 2 |
| Charles | 2 |
| Chemistry | 2 |
| Chemoprophylaxis | 2 |
| Chemotherapy | 2 |
| Chest | 2 |
| Chicago | 2 |
| Caspofungin | 2 |
| Carlos | 2 |
| Caribbean | 2 |
| CS | 2 |
| CErg | 2 |
| CHD | 2 |
| CKO | 2 |
| CLBSI | 2 |
| CPPS | 2 |
| CR | 2 |
| CYT003A | 2 |
| Carbohydrate | 2 |
| Calmette | 2 |
| Campaign | 2 |
| Cance | 2 |
| Candidemia | 2 |
| Capacity | 2 |
| Carbapenemases | 2 |
| Chien | 2 |
| Chikungunya | 2 |
| ChinaeJapan | 2 |
| Controlled | 2 |
| Condition | 2 |
| Conference | 2 |
| Construction | 2 |
| Consumption | 2 |
| Contaminant | 2 |
| Contamination | 2 |
| Cooper | 2 |
| Comunitaria | 2 |
| Cooperative | 2 |
| Court | 2 |
| Coxiella | 2 |
| Coxsackie | 2 |
| CphA | 2 |
| Cross | 2 |
| Concerned | 2 |
| Comprehensive | 2 |
| Chokshi | 2 |
| Clone | 2 |
| Churchill | 2 |
| Cislaghi | 2 |
| Clavulanic | 2 |
| Clean | 2 |
| Clemente | 2 |
| Cliodna | 2 |
| Clostridium | 2 |
| Common | 2 |
| ClpP | 2 |
| Coccidioides | 2 |
| Coccidioidomycosis | 2 |
| Coconut | 2 |
| Combettes | 2 |
| Combination | 2 |
| Nikolich | 2 |
| ESICM | 2 |
| Norasept | 2 |
| edn | 2 |
| defensins | 2 |
| del | 2 |
| des | 2 |
| diagnosticados | 2 |
| diagnóstico | 2 |
| diaminoalkane | 2 |
| diclofenac | 2 |
| dicloxacillin | 2 |
| diet | 2 |
| diphenylphosphoryl | 2 |
| dodecyl | 2 |
| doramectin | 2 |
| dysphagia | 2 |
| ebola | 2 |
| echinocandin | 2 |
| daunosamine | 2 |
| daptomycin | 2 |
| dang | 2 |
| coccidiosis | 2 |
| cient | 2 |
| ciprofloxacin | 2 |
| classifi | 2 |
| clavulante | 2 |
| clone | 2 |
| coagulasenegative | 2 |
| comensales | 2 |
| da | 2 |
| compactin | 2 |
| con | 2 |
| condyloma | 2 |
| coxsackievirus | 2 |
| crecimiento | 2 |
| d'une | 2 |
| eco | 2 |
| eds | 2 |
| cephalosporin | 2 |
| egy | 2 |
| genotype-1 | 2 |
| glmnet | 2 |
| gumma | 2 |
| hCoV | 2 |
| hMPV | 2 |
| hRV | 2 |
| hVISA | 2 |
| health | 2 |
| hematogenous | 2 |
| hepatisation | 2 |
| hepatosplenomegaly | 2 |
| hereinafter | 2 |
| heterocycle | 2 |
| http:// | 2 |
| http://www | 2 |
| gemtuzumab | 2 |
| gemifloxacin | 2 |
| gattii | 2 |
| exchange | 2 |
| emm | 2 |
| enterica | 2 |
| enterobacteria | 2 |
| epirubicin | 2 |
| epothilones | 2 |
| estudio | 2 |
| faringitis | 2 |
| gangrenosum | 2 |
| faringoamigdalitis | 2 |
| flurbiprofen | 2 |
| freundii | 2 |
| fumarate | 2 |
| g. | 2 |
| galenic | 2 |
| chem | 2 |
| ceftobiprole | 2 |
| Viruses | 2 |
| adenopathy | 2 |
| Wyeth | 2 |
| X. | 2 |
| XG | 2 |
| Year | 2 |
| Yellow | 2 |
| Yilmaz | 2 |
| Yorkshire | 2 |
| Young | 2 |
| Z | 2 |
| Zeimet | 2 |
| Zhao | 2 |
| Zhongguo | 2 |
| Zhonghua | 2 |
| Zmax | 2 |
| Zurawski | 2 |
| Wright | 2 |
| Willie | 2 |
| Williams | 2 |
| Weaver | 2 |
| Vulvovaginal | 2 |
| WBCs | 2 |
| WK | 2 |
| WXL | 2 |
| Wald | 2 |
| Watson | 2 |
| Webber | 2 |
| Wild | 2 |
| Weimer | 2 |
| White | 2 |
| Whiteside | 2 |
| Whole | 2 |
| Whyte | 2 |
| Wikler | 2 |
| actinobacteria | 2 |
| agglomerans | 2 |
| ceftiofur | 2 |
| amidases | 2 |
| bacteremic | 2 |
| biosynthesis | 2 |
| burnetii | 2 |
| cadang | 2 |
| calicheamicin | 2 |
| candidemia | 2 |
| carbapenemases | 2 |
| carbenicillin | 2 |
| case | 2 |
| catio | 2 |
| cefadroxil | 2 |
| cefdinir | 2 |
| cefixime | 2 |
| cefprozil | 2 |
| ceftaroline | 2 |
| bacteraemia | 2 |
| bacille | 2 |
| b. | 2 |
| antimicrobiano | 2 |
| amino | 2 |
| aminobenzoxaborole | 2 |
| anthracycline | 2 |
| anthracyclines | 2 |
| antibiotikaresistens | 2 |
| antigen | 2 |
| análisis | 2 |
| avermectins | 2 |
| arthralgias | 2 |
| aspartate | 2 |
| association | 2 |
| asthma | 2 |
| author(s | 2 |
| autolysins | 2 |
| hyaluronan | 2 |
| hydrolase | 2 |
| ic | 2 |
| streptozotocin | 2 |
| respiratorio | 2 |
| rhinorrhea | 2 |
| ribosomal | 2 |
| rifaximin | 2 |
| rst | 2 |
| rápida | 2 |
| secretary | 2 |
| sepiolite | 2 |
| series | 2 |
| serovar | 2 |
| signifi | 2 |
| sinusitis | 2 |
| sociale | 2 |
| species | 2 |
| spectrum | 2 |
| resistance | 2 |
| redoses | 2 |
| rap^.^ | 2 |
| problème | 2 |
| polycationic | 2 |
| por | 2 |
| postprescription | 2 |
| prescripción | 2 |
| presse | 2 |
| primaria | 2 |
| procalcitonin | 2 |
| q12h | 2 |
| profession | 2 |
| profi | 2 |
| publique | 2 |
| pylori | 2 |
| pyoderma | 2 |
| pyrazinamide | 2 |
| spirometric | 2 |
| strongyloidiasis | 2 |
| ie | 2 |
| subinhibitory | 2 |
| varicella | 2 |
| vasculopathy | 2 |
| venereum | 2 |
| vet | 2 |
| vétérinaires | 2 |
| whipplei | 2 |
| zur | 2 |
| × | 2 |
| α | 2 |
| γ | 2 |
| Ϫ0.1 | 2 |
| у1 | 2 |
| у2 | 2 |
| ≥38 | 2 |
| Norms | 2 |
| vanB | 2 |
| valens | 2 |
| un | 2 |
| table | 2 |
| submicromolar | 2 |
| substituent | 2 |
| sulfa | 2 |
| sylviforme | 2 |
| synthetase | 2 |
| tRNA | 2 |
| tedizolid | 2 |
| ts/-Em | 2 |
| tenofovir | 2 |
| thiabendazole | 2 |
| thrombophlebitis | 2 |
| transferase | 2 |
| trihydrate | 2 |
| tropicalis | 2 |
| pneumonia | 2 |
| plantationocene | 2 |
| pili | 2 |
| pharyngotonsillar | 2 |
| lipopolysaccharides | 2 |
| lm | 2 |
| loop2 | 2 |
| lowrisk | 2 |
| lukF | 2 |
| lukS | 2 |
| lwoffii | 2 |
| lymphogranuloma | 2 |
| lymphopenia | 2 |
| mM | 2 |
| mSystems | 2 |
| macrocycle | 2 |
| macrocyclic | 2 |
| maraviroc | 2 |
| marinum | 2 |
| leucyl | 2 |